ALEX is the first in vitro multiplex allergy test allowing simultaneous measurement of total IgE (tIgE) and specific IgE (sIgE) against a plethora of allergen extracts and molecular allergens.
Based on our test panels composition of allergen extracts and molecular allergens, a near complete picture of each patient’s sensitization status is obtained. ALEX is based on our proprietary nano-bead technology. Every allergen (extract) can be individually optimized for production. The flexible analysis software, allows our customers to analyze tailormade allergen panels as they see fit for their clinical needs – Multiplex on demand.
The ALEX assay protocol integrates a powerful Cross-reactive Carbohydrate Deteminants (CCDs) inhibitor during serum incubation, which will clear up your specific IgE results. This reduces the interpretative burden for physicians of CCD positive patients and increases the specificity of our test results.
- Simultaneous measurement of total and specific IgE
- Near-complete allergen panel, individually optimized
- Multiplex test with on-demand panel composition
- Integrated CCD inhibition